Details for New Drug Application (NDA): 204287
✉ Email this page to a colleague
The generic ingredient in EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE is efavirenz; emtricitabine; tenofovir disoproxil fumarate. There are twenty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the efavirenz; emtricitabine; tenofovir disoproxil fumarate profile page.
Summary for 204287
Tradename: | EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | efavirenz; emtricitabine; tenofovir disoproxil fumarate |
Patents: | 0 |
Suppliers and Packaging for NDA: 204287
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | efavirenz; emtricitabine; tenofovir disoproxil fumarate | TABLET;ORAL | 204287 | ANDA | Macleods Pharmaceuticals Limited | 33342-138 | 33342-138-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-138-07) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG;200MG;300MG | ||||
Approval Date: | Sep 13, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription